Replies to post #341156 on Amarin Corp Plc (AMRN)

[biotech_researcher]

WOW!

[rosemountbomber]

Thanks Raf. Wow shocking numbers.

[lizzy241]

thanks Raf, it appears that GV found a supply from somewhere.

[Retired2019]

Did the U.S. Sales Team Quit ???

Is Amarin blowing off the U.S. market to prepare for EU rollout? Who is paying attention to U.S.?

Where are the 2 CEO's ?????????

[Skipperdog11]

The only positive that these numbers show is that the often denigrated (albeit unfairly) Amarin sales effort is actually quite effective and is doing a good job. The market is being cultivated, educated and grown completely at the expense of a tiny company in Bridgewater New Jersey. Looks like this "winning strategy" is being doubled down on by leadership and will continue to provide great sources of "hey mom, look what I got" revenue for the generics for years to come. Time to face simple realities. The legal system gets us nowhere. The trial will go forward. The Judge is not a pushover that is somehow unable to see the clear points that were made two days ago- but be careful what you wish for. The district court and the appeal process will take every bit of 5 years or more with outcomes uncertain until the very end. The generics are not fearful in anyway of treble damages- they know this is a farce based on the actions in Nevada and then the CAFC. The supply issues are temporary. Profit is the great motivator that will take care of supply chain inadequacies in short order. The quality of the encapsulation method will not be much of an issue as oxidation is a concern for thousand of products that are encapsulated.

Time to reduce the US footprint ASAP! Amarin needs a generic offering and all eyes should be focused on Europe.

Just had to rant! I did make my first buy since early last year yesterday.

[ralphey]

The total gV up is nearly identical to the V down - meaning they are eating AMRN'S lunch ....

AMRN needs to line up more insurers and start suing them for damages - and look forward -

What is AMRN going to do if Insurers they sue refuse to cover any form of V ? Are they going to help patients file law suits for health damages ?

and of course in true AMRN fashion ..on this bad news of RX numbers stock price rises ....

[iryokabu]

Pain up to 16,000 scripts/week is expected based on generics' capacity.

[Invest83838]

Thank You Judge Du

For your pathetic politically corrupt ruling

that is literally killing people

because your ruling has indirectly allowed Generic Vascepa

to infringe on Amarin's REDUCE-IT indications

with the assistance of ignorant

insurance companies, pharmacists, and doctors

[MNBioMike]

What in the serious fu@k is happening during these 40,000 hours per week?

[invest2992]

Really glad I searched for this post of last weeks sales. Seems like it’s time to fire a lot of dead wood sales people. And he head of marketing. Can’t believe how bad the numbers are.

[rafunrafun]

Sripts for week ending May 28, 2021.

Overall drug TRx are +2.5% w/w.

Vascepa
TRx 84,510; +2.8% (+2,285) w/w; +8.0% y/y
NRx 37,467; +2.8% (+1,017) w/w; +12.2% y/y
Ref 47,043; +2.8% (+1,268) w/w; +4.8% y/y

Generic Vascepa
TRx 11,090; -10.2% (-1263) w/w; As % of total V: 11.6%
NRx 6,215; -8.4% (-569) w/w; As % of total V: 14.2%
Ref 4,875; -12.5% (-694) w/w; As % of total V: 9.4%

Lovaza (Generic & Brand)
TRx 63,223; +0.9% (+551) w/w; +17.2% y/y
NRx 30,867; +1.4% (+439) w/w; +25.9% y/y
Ref 32,356; +0.3% (+112) w/w; +10.0% y/y